AwardTape Companies Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

#24,341 by obligations / 44.4/100 Score / $367K obligated (FY24+) / 4 awards / 87.8% no-bid among largest contracts / Feb 18, 2026 latest action

Browse every contractor

Adaptive Biotechnologies Corporation / 4 awards / $367K obligated (FY24+)

Get a free API key API JSON

Executive Capture & Competitive PositionWhat this company is, who pays it, where it can grow or lose

Market RoleEmerging EntrantNot in Top 100 directory

Primary Buying CommandDepartment of the Army67.0% of FY24+ obligations

Vehicle SeatsNone foundNo parent-vehicle orders in FY24+

Country FootprintUS onlyNo allied ministry awards on file

Recompetes Next 12 MonthsNone in watchlistTop 300 expiring awards checked

Company Score & Key Metrics#24,341 by obligations / Small contractor

Overall Score

44.4 / 100

Score based on the largest 50 contracts

Obligations & YoY

$367K (+150.0%)

$76K - $162K - $129K

No-Bid Share

87.8%

Sole-source share of the largest 50 contracts

Unused Ceiling

$615K

0 vehicles / 2 agencies / 3 offices

SAM.gov registration and exclusionsChecked 2026-11-11 / About this data

No active exclusion found for this UEI, CAGE or legal name.

Registration	Active (expired) / All awards / expires 2026-11-04
Legal name	ADAPTIVE BIOTECHNOLOGIES CORPORATION
Address	1165 EASTLAKE AVE E, SEATTLE, WA, 98109, USA / district 07
Structure	Corporate entity (not tax exempt), incorporated in WA / in business since 2009-09-08
NAICS	621511 (+1 more)
API	registration JSON / SAM.gov record

Contracts & Orders4 available contract records (FY2024+), largest first

Contract ID	Obligated (FY24+)	Type	Agency	Category	Description	Latest Action
W81K0025CA004	$246K	definitive contract	Department of the Army	Health care services	Clonoseq fda-cleared in vitro diagnostic (ivd) testing services	Feb 18, 2026
HT942524P0095	$76K	purchase order	Defense Health Agency	Defense systems R&D	Adaptive immunosequencing service	Jul 3, 2024
HT001425P0034	$45K	purchase order	Defense Health Agency	Health care services	Clonoseq has received clearance from the food and drug administration for an in vitro diagnostic test service that detects blood cancer in patients.	Nov 26, 2025
HT001419C0006	$0	definitive contract	Defense Health Agency	Health care services	Clonoseq minimal residual disease in-vitro diagnostic array for the department of pathology at walter reed national military medical center	Aug 29, 2024

Unused ceiling is uncommitted capacity across available contract records, not guaranteed spending. Vehicle details summarize the largest 500 records.

Buying AgenciesFY2024+

#	Agency	Awards	Obligated	Share
1	Department of the Army	1	$246K	67%
2	Defense Health Agency	3	$121K	33%

Product & Service CategoriesFY2024+

#	Category	Awards	Obligated	Share
1	Health care services	3	$291K	79%
2	Defense systems R&D	1	$76K	21%

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 24, 2026.

Export Custom Datasets or Query the AwardTape API

Select from 6 core datasets (Contractors, Contract Instruments, Expiring Recompetes, Allied Procurement, HV Grid Queue, Sanctions/UFLPA), filter by company, ticker, or PIID, and export in CSV, JSON, or Markdown Brief.

Search & Export Datasets Get a free API key Compare Plans

Building an AI agent? Get this company profile as JSON: GET /api/agent/v1/companies/adaptive-biotechnologies. Schema, sample and price or start with free sample calls.